InMed Pharmaceuticals Inc.
MTRINext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for MTRI. That does not mean none is planned.
Get an email about MTRI's next catalysts
Track InMed Pharmaceuticals (MTRI) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 3 past
No catalysts found.
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
INM-755 (cannabinol) cream | Phase 2 | Epidermolysis Bullosa Simplex | - | - |
Frequently asked questions
What is in InMed Pharmaceuticals Inc.'s drug pipeline?β
CatalystAlert tracks 1 drug candidate in InMed Pharmaceuticals Inc.'s (MTRI) pipeline across Phase 2. Its lead program is INM-755 (cannabinol) cream (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is InMed Pharmaceuticals Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for InMed Pharmaceuticals Inc. (MTRI) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track MTRI biotech catalysts?β
Add MTRI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow InMed Pharmaceuticals Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
